Innoviva Inc.

(INVA) Trade

By |

Profile

Innoviva Inc is a biopharmaceutical company that is engaged in the discovery, development and commercialization of small molecule medicines. The firm collaborates with and receives funding from GlaxoSmithKline.

Contact Information

Website: www.inva.com
Email: investor.relations@theravance.com
Main Phone: +1 650 238-9600
Address: 2000 Sierra Point Parkway
Address 2: Suite 500
State: CA
City / Town: Brisbane
Country: USA
Postal Code: 94005

Issuer Information

Exchange: NGS
CEO: Eric d'Esparbes
Employees: 10
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 14.96 $ 0.34 (2.33%)
Last Price 14.96 Change $ 0.34 Change % 2.33 Tick N/A
Bid 11.80 Bid Size 100.00 Ask 15.00 Ask Size 2,000.00
Open 14.64 High 15.03 Low 14.62 Prev Close 14.62
Last Trade Volume 828,025 52 Wk Hi 17.99 52 Wk Low 11.47
Market Cap 1.5 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 101,507,745.00 EPS (TTM) 1.47 PE Ratio 9.90 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 18
Number of Buys 0 2
Number of Sells 0 16
Net Activity 0 -117433
Last 10 Buys Shares
N/A 0
Last 10 Sell Shares
Michael W. Aguiar 1,000
Theodore L. Witek 1,000
George B. Abercrombie 1,000
Eric d'Esparbes 1,000
Eric d'Esparbes 1,000
Eric d'Esparbes 1,000
Eric d'Esparbes 1,000
Theodore L. Witek 1,000
Eric d'Esparbes 1,000
Theodore L. Witek 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 16 16 16 16
Low Target Price Estimate 8 8 8 8
Mean Target Price Estimate 12.75 12.75 12.8 12.75
Standard Deviation 3.4 3.4 2.95 3.4
Date of Most Recent Estimate 05/11/18 05/11/18 05/11/18 05/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 2 3 3 3
Moderate Sell 1 1 1 1
Strong Sell 1 1 1 1
Mean Rec. 3.58 3.46 3.46 3.46